Developer docs
API playgroundTry for free, no card

Search company profiles

Falorni

Full company profile

uuid000kzbv

Namestring
Falorni
Legal namestring
Falorni S.r.l.
Company typeenum
Private
Founded yearint
1954
Descriptiontext

Falorni S.r.l. is an Italian pharmaceutical Contract Development and Manufacturing Organization (CDMO) founded in 1954 in Florence, operating as a privately held group with two divisions: Falorni Pharma and Falorni Nutra. Falorni Pharma provides contract secondary packaging (50+ million packages/year on double shifts), serialization and aggregation across EU, USA, Russia, KSA, and China markets via four customized lines (partnered with Antares Vision), manual visual inspection (1.5 million vials/year), batch reconditioning, batch record release with on-site Qualified Persons, packaging material procurement, and integrated GDP-compliant logistics including cold chain (2-8°C) and controlled substances storage. The company serves pharmaceutical manufacturers producing standard and specialty products including sterile injectables, ophthalmics, narcotics, blood derivatives, and orphan drugs.

Falorni Nutra, established in 2019, extends the pharmaceutical DNA into probiotic and food supplement CDMO services, operating a 5,000+ sqm GMP facility with dedicated HVAC systems controlling humidity down to 20% Rh, double air-lock contamination prevention, and scale-up capabilities through 10L, 100L, and 500L mixers. The Nutra division offers full-service product development from idea screening through formulation, prototype, clinical study management, and commercial manufacturing of bulk powders, hard capsules, blister packs, and stick packs.

Revenue is generated through customized quote-based B2B contracts with pharmaceutical and nutraceutical companies, sold through direct enterprise field sales with dedicated project managers and long-term co-investment partnership models. The go-to-market is relationship-driven, targeting primarily Italian and European pharmaceutical enterprises; a logo list includes 21+ named clients including Menarini, Recordati, Alfasigma, Dompè, Lilly, Aurobindo, Fidia, Molteni, Farmigea, and Urgo. Regulatory authorizations span GMP (human and food supplements), ISO 13485 medical devices, and Italian Ministerial Decrees for veterinary medicinal products and controlled substances, providing a meaningful regulatory moat. The company is owned by a private group that acquired it from Procter & Gamble in 2001; no venture capital or institutional investor involvement is disclosed.

Short descriptiontext

Falorni is an Italian pharmaceutical CDMO (founded 1954) operating Falorni Pharma for contract packaging, serialization, and visual inspection, and Falorni Nutra for probiotic and food supplement manufacturing, serving enterprise pharma and nutraceutical clients globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSesto Fiorentino, Italy
HQ citystring
Sesto Fiorentino
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical contract packaging, pharmaceutical CDMO services, serialization and aggregation, probiotic manufacturing, nutraceutical product development
Industry2 codes
PRIMARYHLAGABAJ
Packaging, Labeling & Serialization (Clinical/Commercial) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
NAICS code3 codes
  • Pharmaceutical and Medicine Manufacturing3254
  • Medicinal and Botanical Manufacturing325411
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Medicinal Chemicals & Botanical Products2833
Product category
Pharmaceutical Contract Manufacturing and Packaging
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Contract Packaging Services
TypeProfessional Services
Description

Secondary packaging of pharmaceutical products including liquids, solids, sterile injectables, ophthalmic products, and medicated patches. Services include serialization, aggregation, labeling, and batch reconditioning. Revenue generated through service contracts with pharmaceutical companies.

falornipharma.com
2CDMO Manufacturing Services
TypeProfessional Services
Description

Contract development and manufacturing of finished probiotic and food supplement products. Includes bulk powder mixing, hard capsules, blister packaging, bottle packaging, and stick packs. Full service from R&D through production release.

falornipharma.com
3Logistics and Supply Chain Services
TypeManaged Services
Description

Integrated logistics including warehousing, temperature-controlled storage, cold chain management, and distribution. Manages semi-finished and finished products through the pharmaceutical supply chain.

falornipharma.com
4R&D and Clinical Study Services
TypeProfessional Services
Description

Product development services including idea conceptualization, formulation, clinical study management, and regulatory support. Single point of contact integrating R&D, clinical studies, and final production.

falornipharma.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Falorni is a Contract Development and Manufacturing Organization (CDMO) for pharmaceutical and nutraceutical companies, organized into Falorni Pharma and Falorni Nutra. It provides contract secondary packaging, serialization and aggregation compliant with EU/USA/Russia/KSA/China regulations, manual visual inspection, batch release, reconditioning, and GDP-compliant cold chain logistics. It also provides full-service probiotic and food supplement development from idea and formulation through prototype, clinical study, scale-up, and GMP manufacturing in a 5,000+ sqm facility with dedicated HVAC and contamination control.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Over 50 million packages produced annually
+3 more records
Product overview1 text field

Falorni is a Contract Development and Manufacturing Organization (CDMO) operating since 1954, organized into two divisions: Falorni Pharma for pharmaceutical contract packaging and Falorni Nutra for probiotic and food supplement manufacturing. Falorni Pharma offers secondary packaging (50+ million packages/year capacity), serialization and aggregation (4 lines, EU/USA/Russia/KSA/China markets), visual inspection (1.5 million pieces/year), logistics, packaging material procurement, batch record release, and batch reconditioning services. Falorni Nutra provides full-service product development from idea through manufacturing, including formulation, prototype and scale-up (10-500L mixers), clinical studies, and GMP manufacturing for probiotics and food supplements (5,000 sqm facility with dedicated HVAC for humidity control to 20% Rh). The company integrates R&D, clinical studies, and production with a centralized monitoring system and holds GMP, ISO 13485, and Italian ministerial authorizations.

Product and service15 records
1Secondary Packaging
CategoryPharmaceutical contract packaging
Description

Contract secondary packaging services for pharmaceutical products including liquids, solids, semi-solids, sterile injectables, ophthalmic products, and medicated patches on automated and semi-automatic lines. Yearly capacity exceeds 50 million packages on double shifts.

2Serialization and Aggregation
CategoryPharmaceutical packaging compliance
Description

End-to-end and track-and-trace serialization and aggregation services across 4 customized lines plus a dedicated big and custom box serialization line, ensuring FMD anti-counterfeiting compliance for pharmaceutical clients.

3Visual Inspection
CategoryPharmaceutical quality control services
Description

Manual visual inspection for standard and special vials, PET vials with overwrap, pre-filled syringes, and lyophilisates, with annual volumes of approximately 1.5 million pieces.

4Logistics
CategoryPharmaceutical logistics and distribution
Description

Full GDP-compliant logistics management for semi-finished and finished pharmaceutical products including warehousing, temperature-sensitive and cold chain handling, and distribution with temperature monitoring devices.

5Packaging Material Procurement
CategoryPharmaceutical packaging services
Description

Purchase, management, and quality control of pharmaceutical packaging materials including labels, boxes, and inserts, supported by print proof software that scans texts and characteristics of printed materials.

6Batch Record Release
CategoryPharmaceutical regulatory services
Description

Batch release documentation services with on-site Qualified Persons (QP) who can release batches to the market and ensure compliance with safety, quality, and regulatory standards.

7Batch Reconditioning
CategoryPharmaceutical packaging services
Description

Dynamic batch reconditioning services for pharmaceutical products including blister labeling, replacement of package inserts and cartons, un-labeling and re-labeling of bottles, and application of labels on already printed data.

8Falorni Pharma (Sub-brand)
CategoryPharmaceutical CDMO
Description

Pharmaceutical CDMO sub-brand providing secondary packaging, serialization, visual inspection, logistics, batch release, and reconditioning since 1954.

9Idea to Product Development
CategoryNutraceutical R&D services
Description

Full-service product development from idea to market-ready formulation, including therapeutic area assessment, molecule screening, and preliminary solution screening conducted by the R&D team.

10Formulation
CategoryNutraceutical R&D services
Description

Product formulation services ensuring standards of stability, homogeneity, and effectiveness, with R&D team proposing new and technologically advanced solutions for industrialization.

11Price and Market Orientation
CategoryNutraceutical commercialization services
Description

Business development services for market segment selection and strategy, including formulation adjustments to determine the best product for a given market context.

12Prototype and Scale-up
CategoryNutraceutical manufacturing scale-up services
Description

Formulation development with 10L, 100L, and 500L mixers to evaluate scale-up characteristics from early development through industrial production.

13Clinical Study
CategoryNutraceutical clinical research services
Description

Clinical trial development services covering regulatory, strategic, logistical, and monitoring phases, leveraging over a decade of partnerships with clinical study providers.

14GMP Manufacturing for Probiotics and Food Supplements
CategoryNutraceutical contract manufacturing
Description

GMP manufacturing for probiotics and food supplements including bulk powder mixing, hard capsules (sizes 00, 0, 1, 3), blister packs, bottles, and stick packs in a 5,000+ sqm facility with HVAC humidity control down to 20% Rh.

15Falorni Nutra (Sub-brand)
CategoryNutraceutical CDMO
Description

Nutraceutical CDMO sub-brand specializing in high-level probiotics and food supplements with GMP manufacturing capabilities for live and viable probiotic products.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or Integration
Description

Strategic partnership with Antares Vision, a global leader in integrated serialization systems. This partnership enables Falorni to offer services compliant with the latest FMD (Falsified Medicines Directive) anti-counterfeiting legislation. Antares Vision provides the serialization technology infrastructure that supports Falorni's track-and-trace capabilities across multiple international markets.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based pharmaceutical CDMO offering contract manufacturing, analytical, and packaging services across sterile and solid dosage forms — comparable mid-sized CDMO service mix.

TypeDirect peer
Description

Global supplier of pharmaceutical processing and packaging machinery and integrated services — comparable in packaging-line solutions and serialization, though more equipment-focused than service-focused.

TypeRegional player
Description

Italian pharmaceutical contract manufacturer offering secondary packaging and small-batch production — comparable Italian-headquartered CDMO with overlapping packaging focus.

TypeDirect peer
Description

Pharmaceutical packaging solutions provider with drug-delivery, elastomeric, and serialization/aggregation services — directly comparable to Falorni's secondary packaging and serialization offering.

TypeDirect peer
Description

Italian pharmaceutical packaging specialist offering primary containers, closures, and packaging services — directly comparable Italian-headquartered pharma packaging peer to Falorni.

TypeBroad incumbent
Description

Global pharmaceutical CDMO incumbent offering contract packaging, serialization, and clinical/commercial supply across multiple dosage forms — much larger scale but overlapping pharma CDMO services.

TypeBroad incumbent
Description

Global life-sciences testing and CDMO platform (including Cambrex acquisition) offering pharmaceutical development, manufacturing, and packaging services — broader scope but overlapping pharma CDMO functions.

TypeDirect peer
Description

European pharmaceutical CDMO specializing in API development, particle engineering, and contract manufacturing with GMP facilities — comparable pharma CDMO service model and European base.

TypeDirect peer
Description

European pharmaceutical CDMO offering API manufacturing, finished dosage forms, and packaging services — comparable CDMO service portfolio with strong European pharma customer base.

10Recipharm
TypeDirect peer
Description

European-headquartered pharmaceutical CDMO offering contract manufacturing and secondary packaging for solid, semi-solid, and sterile dosage forms — directly comparable business model and service mix to Falorni Pharma.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers16 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Falorni

Pharmaceutical Contract Manufacturing and Packagingfalornipharma.com

Falorni is an Italian pharmaceutical CDMO (founded 1954) operating Falorni Pharma for contract packaging, serialization, and visual inspection, and Falorni Nutra for probiotic and food supplement manufacturing, serving enterprise pharma and nutraceutical clients globally.

What Falorni does

Falorni S.r.l. is an Italian pharmaceutical Contract Development and Manufacturing Organization (CDMO) founded in 1954 in Florence, operating as a privately held group with two divisions: Falorni Pharma and Falorni Nutra. Falorni Pharma provides contract secondary packaging (50+ million packages/year on double shifts), serialization and aggregation across EU, USA, Russia, KSA, and China markets via four customized lines (partnered with Antares Vision), manual visual inspection (1.5 million vials/year), batch reconditioning, batch record release with on-site Qualified Persons, packaging material procurement, and integrated GDP-compliant logistics including cold chain (2-8°C) and controlled substances storage. The company serves pharmaceutical manufacturers producing standard and specialty products including sterile injectables, ophthalmics, narcotics, blood derivatives, and orphan drugs.

Falorni Nutra, established in 2019, extends the pharmaceutical DNA into probiotic and food supplement CDMO services, operating a 5,000+ sqm GMP facility with dedicated HVAC systems controlling humidity down to 20% Rh, double air-lock contamination prevention, and scale-up capabilities through 10L, 100L, and 500L mixers. The Nutra division offers full-service product development from idea screening through formulation, prototype, clinical study management, and commercial manufacturing of bulk powders, hard capsules, blister packs, and stick packs.

Revenue is generated through customized quote-based B2B contracts with pharmaceutical and nutraceutical companies, sold through direct enterprise field sales with dedicated project managers and long-term co-investment partnership models. The go-to-market is relationship-driven, targeting primarily Italian and European pharmaceutical enterprises; a logo list includes 21+ named clients including Menarini, Recordati, Alfasigma, Dompè, Lilly, Aurobindo, Fidia, Molteni, Farmigea, and Urgo. Regulatory authorizations span GMP (human and food supplements), ISO 13485 medical devices, and Italian Ministerial Decrees for veterinary medicinal products and controlled substances, providing a meaningful regulatory moat. The company is owned by a private group that acquired it from Procter & Gamble in 2001; no venture capital or institutional investor involvement is disclosed.

Falorni firmographics

Firmographics
Name
Falorni
Legal name
Falorni S.r.l.
Website
https://falornipharma.com
Company type
Private
Founded year
1954
Operating status
Operating
Headcount range
51–100 employees
Short description
Falorni is an Italian pharmaceutical CDMO (founded 1954) operating Falorni Pharma for contract packaging, serialization, and visual inspection, and Falorni Nutra for probiotic and food supplement manufacturing, serving enterprise pharma and nutraceutical clients globally.
Ownership category
akta.pro rank

Falorni industry classification

Industry
Product category
Pharmaceutical Contract Manufacturing and Packaging
NAICS
Pharmaceutical and Medicine Manufacturing (3254), Medicinal and Botanical Manufacturing (325411), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731), Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYHLAGABAJ
Packaging, Labeling & Serialization (Clinical/Commercial) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

Keywords

  • Pharmaceutical contract packaging
  • Pharmaceutical CDMO services
  • Serialization and aggregation
  • Probiotic manufacturing
  • Nutraceutical product development

Where Falorni is headquartered

Location

Headquarters

HQ city
Sesto Fiorentino
HQ country
Italy
HQ region
Europe

Offices1 record

Markets served

Falorni business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

  1. Contract Packaging Services: Secondary packaging of pharmaceutical products including liquids, solids, sterile injectables, ophthalmic products, and medicated patches. Services include serialization, aggregation, labeling, and batch reconditioning. Revenue generated through service contracts with pharmaceutical companies.
  2. CDMO Manufacturing Services: Contract development and manufacturing of finished probiotic and food supplement products. Includes bulk powder mixing, hard capsules, blister packaging, bottle packaging, and stick packs. Full service from R&D through production release.
  3. Logistics and Supply Chain Services: Integrated logistics including warehousing, temperature-controlled storage, cold chain management, and distribution. Manages semi-finished and finished products through the pharmaceutical supply chain.
  4. R&D and Clinical Study Services: Product development services including idea conceptualization, formulation, clinical study management, and regulatory support. Single point of contact integrating R&D, clinical studies, and final production.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Falorni product offering

Product offering

Core offering

Falorni is a Contract Development and Manufacturing Organization (CDMO) for pharmaceutical and nutraceutical companies, organized into Falorni Pharma and Falorni Nutra. It provides contract secondary packaging, serialization and aggregation compliant with EU/USA/Russia/KSA/China regulations, manual visual inspection, batch release, reconditioning, and GDP-compliant cold chain logistics. It also provides full-service probiotic and food supplement development from idea and formulation through prototype, clinical study, scale-up, and GMP manufacturing in a 5,000+ sqm facility with dedicated HVAC and contamination control.

Product overview

Falorni is a Contract Development and Manufacturing Organization (CDMO) operating since 1954, organized into two divisions: Falorni Pharma for pharmaceutical contract packaging and Falorni Nutra for probiotic and food supplement manufacturing. Falorni Pharma offers secondary packaging (50+ million packages/year capacity), serialization and aggregation (4 lines, EU/USA/Russia/KSA/China markets), visual inspection (1.5 million pieces/year), logistics, packaging material procurement, batch record release, and batch reconditioning services. Falorni Nutra provides full-service product development from idea through manufacturing, including formulation, prototype and scale-up (10-500L mixers), clinical studies, and GMP manufacturing for probiotics and food supplements (5,000 sqm facility with dedicated HVAC for humidity control to 20% Rh). The company integrates R&D, clinical studies, and production with a centralized monitoring system and holds GMP, ISO 13485, and Italian ministerial authorizations.

Differentiator

Problem solved

Functional benefit

Products and services

  • Secondary Packaging Contract secondary packaging services for pharmaceutical products including liquids, solids, semi-solids, sterile injectables, ophthalmic products, and medicated patches on automated and semi-automatic lines. Yearly capacity exceeds 50 million packages on double shifts.
  • Serialization and Aggregation End-to-end and track-and-trace serialization and aggregation services across 4 customized lines plus a dedicated big and custom box serialization line, ensuring FMD anti-counterfeiting compliance for pharmaceutical clients.
  • Visual Inspection Manual visual inspection for standard and special vials, PET vials with overwrap, pre-filled syringes, and lyophilisates, with annual volumes of approximately 1.5 million pieces.
  • Logistics Full GDP-compliant logistics management for semi-finished and finished pharmaceutical products including warehousing, temperature-sensitive and cold chain handling, and distribution with temperature monitoring devices.
  • Packaging Material Procurement Purchase, management, and quality control of pharmaceutical packaging materials including labels, boxes, and inserts, supported by print proof software that scans texts and characteristics of printed materials.
  • Batch Record Release Batch release documentation services with on-site Qualified Persons (QP) who can release batches to the market and ensure compliance with safety, quality, and regulatory standards.
  • Batch Reconditioning Dynamic batch reconditioning services for pharmaceutical products including blister labeling, replacement of package inserts and cartons, un-labeling and re-labeling of bottles, and application of labels on already printed data.
  • Falorni Pharma (Sub-brand) Pharmaceutical CDMO sub-brand providing secondary packaging, serialization, visual inspection, logistics, batch release, and reconditioning since 1954.
  • Idea to Product Development Full-service product development from idea to market-ready formulation, including therapeutic area assessment, molecule screening, and preliminary solution screening conducted by the R&D team.
  • Formulation Product formulation services ensuring standards of stability, homogeneity, and effectiveness, with R&D team proposing new and technologically advanced solutions for industrialization.
  • Price and Market Orientation Business development services for market segment selection and strategy, including formulation adjustments to determine the best product for a given market context.
  • Prototype and Scale-up Formulation development with 10L, 100L, and 500L mixers to evaluate scale-up characteristics from early development through industrial production.
  • Clinical Study Clinical trial development services covering regulatory, strategic, logistical, and monitoring phases, leveraging over a decade of partnerships with clinical study providers.
  • GMP Manufacturing for Probiotics and Food Supplements GMP manufacturing for probiotics and food supplements including bulk powder mixing, hard capsules (sizes 00, 0, 1, 3), blister packs, bottles, and stick packs in a 5,000+ sqm facility with HVAC humidity control down to 20% Rh.
  • Falorni Nutra (Sub-brand) Nutraceutical CDMO sub-brand specializing in high-level probiotics and food supplements with GMP manufacturing capabilities for live and viable probiotic products.

Quantifiable outcome

  • Over 50 million packages produced annually
  • +3 more outcomes

Companies that use Falorni

Customer profile

Named customers16 records

Segments2 records

Ideal customer profiles2 records

Falorni technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Falorni partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Antares VisioncoreTechnology or IntegrationStrategic partnership with Antares Vision, a global leader in integrated serialization systems. This partnership enables Falorni to offer services compliant with the latest FMD (Falsified Medicines Directive) anti-counterfeiting legislation. Antares Vision provides the serialization technology infrastructure that supports Falorni's track-and-trace capabilities across multiple international markets.

Scale indicators7 records

Recent moves7 records

Expansion highlights4 records

Falorni competitors and assessment

Company assessment

Direct peers

  • Alcami Corporation: US-based pharmaceutical CDMO offering contract manufacturing, analytical, and packaging services across sterile and solid dosage forms — comparable mid-sized CDMO service mix.
  • ACG Group: Global supplier of pharmaceutical processing and packaging machinery and integrated services — comparable in packaging-line solutions and serialization, though more equipment-focused than service-focused.
  • AptarGroup (Aptar Pharma): Pharmaceutical packaging solutions provider with drug-delivery, elastomeric, and serialization/aggregation services — directly comparable to Falorni's secondary packaging and serialization offering.
  • Bormioli Pharma: Italian pharmaceutical packaging specialist offering primary containers, closures, and packaging services — directly comparable Italian-headquartered pharma packaging peer to Falorni.
  • Hovione: European pharmaceutical CDMO specializing in API development, particle engineering, and contract manufacturing with GMP facilities — comparable pharma CDMO service model and European base.
  • Corden Pharma: European pharmaceutical CDMO offering API manufacturing, finished dosage forms, and packaging services — comparable CDMO service portfolio with strong European pharma customer base.
  • Recipharm: European-headquartered pharmaceutical CDMO offering contract manufacturing and secondary packaging for solid, semi-solid, and sterile dosage forms — directly comparable business model and service mix to Falorni Pharma.

Regional players

  • Procemsa: Italian pharmaceutical contract manufacturer offering secondary packaging and small-batch production — comparable Italian-headquartered CDMO with overlapping packaging focus.

Broad incumbents

  • Catalent: Global pharmaceutical CDMO incumbent offering contract packaging, serialization, and clinical/commercial supply across multiple dosage forms — much larger scale but overlapping pharma CDMO services.
  • Eurofins CDMO: Global life-sciences testing and CDMO platform (including Cambrex acquisition) offering pharmaceutical development, manufacturing, and packaging services — broader scope but overlapping pharma CDMO functions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Falorni social profiles

Digital presence

Falorni compliance and trust

Trust signal

Compliance6 records

Falorni financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Falorni leadership team

Management profile

Number of profiles

Falorni subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Falorni funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Falorni M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Falorni

What does Falorni do?

Falorni is a Contract Development and Manufacturing Organization (CDMO) for pharmaceutical and nutraceutical companies, organized into Falorni Pharma and Falorni Nutra. It provides contract secondary packaging, serialization and aggregation compliant with EU/USA/Russia/KSA/China regulations, manual visual inspection, batch release, reconditioning, and GDP-compliant cold chain logistics. It also provides full-service probiotic and food supplement development from idea and formulation through prototype, clinical study, scale-up, and GMP manufacturing in a 5,000+ sqm facility with dedicated HVAC and contamination control.

Is Falorni a public or private company?

Falorni is a private company. It is classified as unknown and is currently operating.

When was Falorni founded?

Falorni was founded in 1954. It employs 51 to 100 people.

Where is Falorni based?

Falorni is headquartered in Sesto Fiorentino, Italy, in the Europe region.

How does Falorni make money?

Four revenue lines are on record. Contract Packaging Services are the primary driver. The others are CDMO Manufacturing Services, logistics and Supply Chain Services and R&D and Clinical Study Services.

Who are Falorni's main competitors?

Direct peers on record are Alcami Corporation, ACG Group, AptarGroup (Aptar Pharma), Bormioli Pharma, Hovione, Corden Pharma and Recipharm. Procemsa is listed as a regional player. Broad incumbents are Catalent and Eurofins CDMO.

Does Falorni have an API?

No public API is recorded for Falorni.

What industry is Falorni in?

Falorni's product category is Pharmaceutical Contract Manufacturing and Packaging. Its primary akta.pro industry code is HLAGABAJ, Packaging, Labeling & Serialization (Clinical/Commercial) CDMO, with a secondary code of HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO. Its NAICS code is 3254 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales